Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Polycystic Ovary Syndrome 5Weight Loss 3Obesity 3Overweight 2Obesity, Abdominal 1Moderately Overweight Individuals 1Metabolic Syndrome 1Metabolic Diseases 1Menstruation Disturbances 1Intermittent Fasting 1Insulin Resistance 1Glucocorticoid Receptor Deficiency 1Fasting 1Breast Neoplasms 1Breast Cancer Female 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Caloric Restriction × Clear all
NCT02940470 2018-08-03

Weight Loss Pilot Study in Postmenopausal Breast Cancer Survivors

USDA Grand Forks Human Nutrition Research Center

Phase NA Completed
22 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡